Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 41, 882-887, March 1, 1981]
© 1981 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bhuyan, B. K.
Right arrow Articles by Crampton, S. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bhuyan, B. K.
Right arrow Articles by Crampton, S. L.

Intracellular Uptake of 7-con-O-Methylnogarol and Adriamycin by Cells in Culture and Its Relationship to Cell Survival

Bijoy K. Bhuyan1, J. Patrick McGovren and Sheri L. Crampton

Cancer Research, The Upjohn Company, Kalamazoo, Michigan 49001

7-con-O-Methylnogarol (7-OMEN) is a new anthracycline antitumor agent with significant activity in vivo against murine P388 and L1210 leukemia (140% increase in life span) and B16 melanoma (114% increase in life span). We report here the complex relationship that exists between intracellular drug concentration and killing of Chinese hamster ovary (CHO), B16, and L1210 cells in culture by 7-OMEN and Adriamycin.

The uptake of 7-OMEN and Adriamycin by CHO, B16, and L1210 cells was proportional to the extracellular concentration (µg/ml medium) of the drug. At similar concentrations, CHO and B16 cells accumulated more 7-OMEN than Adriamycin. Based on intracellular concentration in CHO cells, Adriamycin was more lethal [lethal dose for 90% of the cells (LD90), 0.02 µg/106 cells] than was 7-OMEN (LD90, 0.1 µg/106 cells). However, based on concentration in CHO cells extracellular 7-OMEN was more lethal (LD90, 0.6 µg/ml) than was Adriamycin (LD90, 2.5 µg/ml). This was probably due to the very low level of uptake of Adriamycin by CHO cells.

For both 7-OMEN and Adriamycin, cell kill increased with increasing intracellular concentration. In contrast to the linear relationship between intracellular concentration and cell kill with Adriamycin, a biphasic relationship was seen with 7-OMEN. For 7-OMEN, cell kill was proportional to intracellular concentration up to approximately 0.04 µg/106 cells. Further increase in intracellular concentration did not result in proportional increase in cell kill.

Exponentially growing cells not only accumulated more 7-OMEN than did plateau-phase cells but were also inherently more sensitive to the drug. This latter conclusion was based on the observation that, even at similar intracellular concentration, more exponentially growing than plateau-phase cells were killed.

Fluorescence microscopy showed that 7-OMEN accumulated predominantly in the cytoplasm, whereas Adriamycin accumulated in the nucleus. The significance of this observation to the mode of action of these drugs is discussed.

1 To whom requests for reprints should be addressed.

Received 4/ 1/80. Accepted 11/13/80.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1981 by the American Association for Cancer Research.